Zhejiang NHU Company Ltd. (002001.SZ)

17.41 +0.11 (+0.64%) At close: 03:04PM CST

Zhejiang NHU Company Ltd.

No.418 Xinchang Dadao West Road
Qixing Sub-district
Xinchang 312500
China
86 575 8612 7777
https://www.cnhu.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 11,526

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Bai Shan Hu	Vice-Chairman & President	N/A	N/A	1967
Mr. Guanqun Shi	CFO, VP, Secretary & Director	N/A	N/A	1971
Mr. Xue Wen Wang	VP & Non-Independent Director	N/A	N/A	1969
Xiaobi Wang	Head of Accounting Department & Non-Employee Supervisor	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Zhejiang NHU Company Ltd. engages in the production and sale of nutritional products, flavor and fragrances, new polymer materials, and APIs in the People's Republic of China. The company offers nutrition products, such as vitamin E, vitamin A, vitamin C, methionine, vitamin D3, biotin, coenzyme Q10, carotenoids, etc. for use in feed additives, and nutrition supplements of food, beverages, health food, etc.; and flavor and fragrance products comprising linalool, citral, and cis-3-hexenol series; methyl dihydrojasmonate; raspberry ketone; and ligustral for use in the personal care, cosmetic, and food fields. It also provides polymer materials, including polyphenylene sulfide and poly phthalamide for use in electronic and electrical, automotive, environmental protection, etc.; and APIs, such as moxifloxacin hydrochloride, vitamin A, vitamin D3, caronic anhydride, azabicyclic, etc. used as active pharmaceutical ingredients for processing and producing pharmaceutical preparations. The company was incorporated in 1999 and is based in Xinchang, the People's Republic of China.

Corporate governance

Zhejiang NHU Company Ltd.’s ISS governance QualityScore as of 1 April 2024 is 8. The pillar scores are Audit: 7; Board: 8; Shareholder rights: 5; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.